Bose expands to whole US with new direct-to-consumer hearing aid

Following positive feedback, consumer electronics company Bose expands sales of its hearing aid catering to persons with mild to moderate hearing impairment, now allowing the product to be purchased over the counter throughout the US rather than starting off in merely five states.

BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY DANIEL FRANK CHRISTENSEN

Published: 13.08.21 at 14:59

All people in the US with mild to moderate hearing impairment are now able to buy hearing aids without seeking adjustment or programming help from audiologists or other healthcare professionals, according to a report from media Hearing Health and Technology Matters.

Bose's hearing aids were, as the first of their kind, approved as over-the-counter (OTC) products back in October of 2018 by the US Food and Drug Administration (FDA). Although Bose didn't release details about the launch before May of this year.

Already a subscriber? Log in.

Read the whole article

Get 14 days free access.
No credit card required.

Access all locked articles
Receive our daily newsletters
Access our app

Start a free company trial today

"Real world" patient data documents the long-term effects of ALK vaccines

Data from ALK's React study, which is a retrospective real-world evidence study including more than 92,000 patients with respiratory allergies, have just been published in the journal The Lancet Regional Health – Europe. | Photo: ALK / PR

In the largest study ever of its kind, patient data from the "real world" documents the long-term effects of up to nine years of ALK vaccines. Up until now, it has not been possible to demonstrate these in ordinary clinical studies where the follow-up period is shorter, and the new knowledge could be a turning point in ALK's dialog about prices and subsidies with authorities and payers.